We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Potential value of pre-planned imaging of bone disease in multiple myeloma.
- Authors
Gundesen, Michael T.; Asmussen, Jon Thor; Schjesvold, Fredrik; Vangsted, Annette Juul; Helleberg, Carsten; Haukås, Einar; Silkjær, Trine; Teodorescu, Elena Manuela; Jensen, Bo Amdi; Slørdahl, Tobias S.; Nahi, Hareth; Waage, Anders; Abildgaard, Niels; Lund, Thomas
- Abstract
Preplanned imaging investigations were performed at months 12 (n = 89), 24 (n = 79), 30 (n = 181), 36 (n = 164) 42 (n = 126) and 48 (n = 93). b Description of findings since last imaging, earlier treatments, type and placement of lesions and results of last treatments for the cases of progressive bone disease seen in a. 1b) Execution of clinically indicated imaging was not delayed due to upcoming preplanned imaging, as the rate of investigations per month per patient was 0.026 1 and 2 months before pre-planned imaging compared to 0.020 3 to 4 months prior to pre-planned imaging. 1Findings of progressive bone disease over time in newly diagnosed multiple myeloma.a Overview of findings of progressive bone disease (PBD) "PBD clinician-initiated imaging" shows cases found due to imaging performed on clinical suspicion of progressive bone disease and cases with biochemical progression or CRAB, "PBD: preplanned imaging" are cases of progressive bone disease found due to preplanned imaging. Dear Editor, International consensus for monitoring bone disease in multiple myeloma (MM) by imaging is to perform these at disease progression or clinical suspicion [[1]].
- Subjects
MULTIPLE myeloma; BONE diseases; PLASMA cell diseases; MONOCLONAL gammopathies
- Publication
Blood Cancer Journal, 2023, Vol 13, Issue 1, p1
- ISSN
2044-5385
- Publication type
Article
- DOI
10.1038/s41408-023-00880-0